Mp58-12 Robot-Assisted Single-Port Transvesical Radical Prostatectomy: Initial Findings From Medium-Term Follow-Up

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy III (MP58)1 May 2024MP58-12 ROBOT-ASSISTED SINGLE-PORT TRANSVESICAL RADICAL PROSTATECTOMY: INITIAL FINDINGS FROM MEDIUM-TERM FOLLOW-UP Adriana M. Pedraza Bermeo, Jaya S. Chavali, Carter Mikesell, Roxana Ramos-Carpinteyro, Nicolas Soputro, and Jihad Kaouk Adriana M. Pedraza BermeoAdriana M. Pedraza Bermeo , Jaya S. ChavaliJaya S. Chavali , Carter MikesellCarter Mikesell , Roxana Ramos-CarpinteyroRoxana Ramos-Carpinteyro , Nicolas SoputroNicolas Soputro , and Jihad KaoukJihad Kaouk View All Author Informationhttps://doi.org/10.1097/01.JU.0001008852.83523.41.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The transition from open radical prostatectomy to minimally invasive robotic techniques has improved intraoperative outcomes while maintaining favorable oncologic results. As such, the emphasis has shifted to tailored approaches that enhance patient comfort and accelerate the return of functional parameters. In alignment with this direction, our team introduced the Single-Port Transvesical Robot-Assisted Radical Prostatectomy (SP TV RARP) in 2020. We aim to present the medium-term follow-up outcomes based on our initial experience. METHODS: From a prospectively maintained database, we assessed patients who underwent SP TV RARP between December 2020 and September 2023 with at least 12 months of follow-up completed. RESULTS: Of the 137 patients included, most were diagnosed with intermediate-risk prostate cancer. The average age was 63 years, with a median PSA of 5.7 ng/ml. The final pathology indicated non-organ confined disease in 42% of the cases, predominantly ISUP GG2. Moreover, 81% exhibited negative surgical margins. The median hospital stay was 5.6 hours (IQR 4.2-21.7). At discharge, 95% did not require opioids, and Foley catheters were removed by day 4 (IQR 3-5). A 5.8% readmission rate was observed, primarily attributed to Clavien-Dindo grade 1 or 2 complications. Regarding urinary continence, 45% achieved immediate control, which increased to 82%, 92%, and 96% by 3, 6, and 12 months, respectively. Of the 107 patients who underwent nerve-sparing surgery, 69% were potent at baseline and the median SHIM score at 12 months was 15 (IQR 5-20) among them. The estimated biochemical recurrence-free survival rate at 26 months reached 94.1% (95% CI 91.3-96.9). CONCLUSIONS: By limiting the surgical technique to a targeted region, minimizing insufflation space, and ensuring the peritoneal cavity's integrity, SP TV RARP optimizes perioperative outcomes. This approach leads to shortened hospital stays, minimal opioid use, and expedited catheter removal. Moreover, it promotes earlier urinary continence, enhancing patient comfort and recovery. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e951 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Adriana M. Pedraza Bermeo More articles by this author Jaya S. Chavali More articles by this author Carter Mikesell More articles by this author Roxana Ramos-Carpinteyro More articles by this author Nicolas Soputro More articles by this author Jihad Kaouk More articles by this author Expand All Advertisement PDF downloadLoading ...